These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 35911521)

  • 1. An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers.
    Santos-Gomes J; Gandra I; Adão R; Perros F; Brás-Silva C
    Front Cardiovasc Med; 2022; 9():924873. PubMed ID: 35911521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Moccaldi B; De Michieli L; Binda M; Famoso G; Depascale R; Perazzolo Marra M; Doria A; Zanatta E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricle performances with echocardiography and
    Liu J; Fei L; Huang GQ; Shang XK; Liu M; Pei ZJ; Zhang YX
    Exp Biol Med (Maywood); 2018 May; 243(9):754-761. PubMed ID: 29763366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
    Hartopo AB; Anggrahini DW; Dinarti LK; Schäfer AK; Bergmann A; Fachiroh J; Somma SD
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.
    Barrier M; Meloche J; Jacob MH; Courboulin A; Provencher S; Bonnet S
    Cell Mol Life Sci; 2012 Sep; 69(17):2805-31. PubMed ID: 22446747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
    Sharma D; Shah RJ; Sreenivasan J; Kafle P; Gupta R; Levine A; Lanier GM; Aronow WS
    Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):543-547. PubMed ID: 35726644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease.
    Tang P
    Hellenic J Cardiol; 2020; 61(1):26-30. PubMed ID: 29890280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension.
    Schäfer M; Wilson N; Ivy DD; Ing R; Abman S; Browne LP; Morgan G; Ross M; McLennan D; Barker AJ; Fonseca B; Di Maria M; Hunter KS; Truong U
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H968-H977. PubMed ID: 30004811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
    Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
    J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Intravascular Ultrasound to Evaluate Pulmonary Vascular Properties and Mortality in Patients with Pulmonary Arterial Hypertension.
    Shen JY; Cai ZY; Sun LY; Yang CD; He B
    J Am Soc Echocardiogr; 2016 Feb; 29(2):103-11. PubMed ID: 26443045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Echocardiographic Tehniques in Pulmonary Arterial Hypertension vs. Right Heart Catheterization - A Pilot Study.
    Constantinescu T; Magda SL; Niculescu R; Mincu RI; Zaharia D; Toma CL; Cinteza M; Bogdan MA
    Maedica (Bucur); 2013 Jun; 8(2):116-23. PubMed ID: 24371474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic implications of perioperative endogenous hydrogen sulfide and nitric oxide levels in children with congenital heart disease complicated by pulmonary arterial hypertension.
    Tan Y; Wang S; Ren X; Zhang C; Xu F
    Eur J Pediatr; 2021 Jun; 180(6):1915-1922. PubMed ID: 33555425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.